Evidence for induced expression of HLA class II on human islets: Possible mechanism for HLA sensitization in transplant recipients

Transplantation

Volumn 87, Issue 4, 2009, Pages 500-506

  Jackson, Andrew M ^a,b   Connolly, John E ^b,c   Matsumoto, Shinichi ^b,d   Noguchi, Hirofumi ^b,d   Onaca, Nicholas ^a   Levy, Marlon F ^a   Naziruddin, Bashoo ^a,b  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b BAYLOR UNIVERSITY   (United States)

^c BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^d BAYLOR RESEARCH INSTITUTE   (United States)

Author keywords

HLA sensitization; Inflammation; Islets; Transplantation

Indexed keywords

GAMMA INTERFERON; HLA ANTIBODY; HLA ANTIGEN CLASS 2; HLA DR7 ANTIBODY; HLA DR7 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ALLOANTIGEN; HLA ANTIGEN; HLA DR ANTIGEN; RNA;

ANTIBODY PRODUCING CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BINDING; RECIPIENT; SENSITIZATION; UPREGULATION; BLOOD; CELL CULTURE; CULTURE MEDIUM; CYTOLOGY; FLOW CYTOMETRY; GENETICS; IMMUNIZATION; IMMUNOLOGY; PANCREAS ISLET; POLYMERASE CHAIN REACTION;

CELLS, CULTURED; CULTURE MEDIA; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLUCAGON-SECRETING CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HLA-DR ANTIGENS; HLA-DR7 ANTIGEN; HUMANS; IMMUNIZATION; INSULIN-SECRETING CELLS; INTERFERON-GAMMA; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; ISOANTIGENS; POLYMERASE CHAIN REACTION; RNA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65649141959     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318195fc33     Document Type: Article

References (20)

1. Shapiro AMJ, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type I diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
2. Shapiro AMJ, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318.
3. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2006; 54: 2060.
4. Ricordi C, Strom TB. Clinical islet transplantation: advances and immunological challenges. Nat Rev Immunol 2004; 4: 259.
5. Campbell PM, Senior PA, Salam A, et al. High risk of sensitization after failed islet transplantation. Am J Transplant 2007; 7: 2311.
6. Mohanakumar T, Narayanan K, Desai N, et al. A significant role for histocompatibility in human islet transplantation. Transplantation 2006; 82: 180.
7. Campbell PM, Salam A, Ryan EA, et al. Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. Am J Transplant 2007; 7: 1242.
8. Olack BJ, Swanson CJ, Flavin KS, et al. Sensitization to HLA antigens in islet recipients with failing transplants. Transplant Proc 1997; 29: 2268.
9. Pujol-Borrell R, Todd I, Doshi M, et al. HLA class II induction in human islet cells by interferon-γ plus tumor necrosis factor or lymphotoxin. Nature 1987; 326: 304.
10. Soldevila G, Boscema M, Doshi M, et al. Cytotoxic effect of IFN gamma plus TNF alpha on human islet cells. J Autoimmun 1991; 4: 291.
11. Ricordi C, Lacy PE, Finke EH, et al. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413.
12. Kim KA, Kim S, Chang I, et al. IFNγ/TNFα synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis. Diabetologia 2002; 45: 385.
13. Foulis AK, Farquharson MA. Aberant expression of HLA DR antigens in insulin containing beta cells in recent onset type 1 (insulin-dependent) diabetes mellitus. Diabetes 1986; 35:1215.
14. Bottazzo GF, Dean BM, McNally JM, et al. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985; 313: 353.
15. Pujol-Borrell R, Todd I, Doshi M, et al. Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas. Clin Exp Immunol 1986; 65: 128.
16. Campbell IL, Bizilj K, Colman PG, et al. Interferon-gamma induces the expression of HLA-A,B,C but not HLA-DR on human pancreatic beta-cells. J Clin Endocrin Metab 1986; 62: 1101.
17. Barshes NR, Wyllie S, Goss JA. Inflammation-mediated dysfunction and apoptosis in islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 2005; 77: 587.
18. Cardani R, Pileggi A, Ricordi C, et al. Allosensitzation of islet allograft recipients. Transplantation 2007; 84: 1413.
19. Lui C, Noorchashm H, Sutter JA, et al. B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat Med 2007; 13: 1295.
20. Bertho N, Drenou B, Laupeze B, et al. HLA-DR-mediated apoptosis susceptibility discriminates differentiation stages of dendritic/monocyte APC. J Immunol 2000; 164:2379.